These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

246 related items for PubMed ID: 9264273

  • 1. Predictive value of molecular dosimetry: individual versus group effects of oltipraz on aflatoxin-albumin adducts and risk of liver cancer.
    Kensler TW, Gange SJ, Egner PA, Dolan PM, Muñoz A, Groopman JD, Rogers AE, Roebuck BD.
    Cancer Epidemiol Biomarkers Prev; 1997 Aug; 6(8):603-10. PubMed ID: 9264273
    [Abstract] [Full Text] [Related]

  • 2. Transient intervention with oltipraz protects against aflatoxin-induced hepatic tumorigenesis.
    Bolton MG, Muñoz A, Jacobson LP, Groopman JD, Maxuitenko YY, Roebuck BD, Kensler TW.
    Cancer Res; 1993 Aug 01; 53(15):3499-504. PubMed ID: 8339253
    [Abstract] [Full Text] [Related]

  • 3. Protection against aflatoxin B1-induced hepatocarcinogenesis in F344 rats by 5-(2-pyrazinyl)-4-methyl-1,2-dithiole-3-thione (oltipraz): predictive role for short-term molecular dosimetry.
    Roebuck BD, Liu YL, Rogers AE, Groopman JD, Kensler TW.
    Cancer Res; 1991 Oct 15; 51(20):5501-6. PubMed ID: 1680553
    [Abstract] [Full Text] [Related]

  • 4. Intermittent dosing with oltipraz: relationship between chemoprevention of aflatoxin-induced tumorigenesis and induction of glutathione S-transferases.
    Primiano T, Egner PA, Sutter TR, Kelloff GJ, Roebuck BD, Kensler TW.
    Cancer Res; 1995 Oct 01; 55(19):4319-24. PubMed ID: 7671242
    [Abstract] [Full Text] [Related]

  • 5. Oltipraz chemoprevention trial in Qidong, People's Republic of China: modulation of serum aflatoxin albumin adduct biomarkers.
    Kensler TW, He X, Otieno M, Egner PA, Jacobson LP, Chen B, Wang JS, Zhu YR, Zhang BC, Wang JB, Wu Y, Zhang QN, Qian GS, Kuang SY, Fang X, Li YF, Yu LY, Prochaska HJ, Davidson NE, Gordon GB, Gorman MB, Zarba A, Enger C, Muñoz A, Helzlsouer KJ.
    Cancer Epidemiol Biomarkers Prev; 1998 Feb 01; 7(2):127-34. PubMed ID: 9488587
    [Abstract] [Full Text] [Related]

  • 6. Levels of aflatoxin-albumin biomarkers in rat plasma are modulated by both long-term and transient interventions with oltipraz.
    Egner PA, Gange SJ, Dolan PM, Groopman JD, Muñoz A, Kensler TW.
    Carcinogenesis; 1995 Aug 01; 16(8):1769-73. PubMed ID: 7634402
    [Abstract] [Full Text] [Related]

  • 7. Evaluation of the cancer chemopreventive potency of dithiolethione analogs of oltipraz.
    Roebuck BD, Curphey TJ, Li Y, Baumgartner KJ, Bodreddigari S, Yan J, Gange SJ, Kensler TW, Sutter TR.
    Carcinogenesis; 2003 Dec 01; 24(12):1919-28. PubMed ID: 14555609
    [Abstract] [Full Text] [Related]

  • 8. Quantitative analysis and chronic dosimetry of the aflatoxin B1 plasma albumin adduct Lys-AFB1 in rats by isotope dilution mass spectrometry.
    Scholl PF, McCoy L, Kensler TW, Groopman JD.
    Chem Res Toxicol; 2006 Jan 01; 19(1):44-9. PubMed ID: 16411655
    [Abstract] [Full Text] [Related]

  • 9. Reduction of aflatoxin B(1) adduct biomarkers by oltipraz in the tree shrew (Tupaia belangeri chinensis).
    Li Y, Su J, Qin L, Egner PA, Wang J, Groopman JD, Kensler TW, Roebuck BD.
    Cancer Lett; 2000 Jun 01; 154(1):79-83. PubMed ID: 10799742
    [Abstract] [Full Text] [Related]

  • 10. Mechanism of protection against aflatoxin tumorigenicity in rats fed 5-(2-pyrazinyl)-4-methyl-1,2-dithiol-3-thione (oltipraz) and related 1,2-dithiol-3-thiones and 1,2-dithiol-3-ones.
    Kensler TW, Egner PA, Dolan PM, Groopman JD, Roebuck BD.
    Cancer Res; 1987 Aug 15; 47(16):4271-7. PubMed ID: 2886217
    [Abstract] [Full Text] [Related]

  • 11. Effects of intermittent exposure to aflatoxin B1 on DNA and RNA adduct formation in rat liver: dose-response and temporal patterns.
    Sotomayor RE, Washington M, Nguyen L, Nyang'anyi R, Hinton DM, Chou M.
    Toxicol Sci; 2003 Jun 15; 73(2):329-38. PubMed ID: 12700393
    [Abstract] [Full Text] [Related]

  • 12. Aflatoxin-albumin adducts: a basis for comparative carcinogenesis between animals and humans.
    Wild CP, Hasegawa R, Barraud L, Chutimataewin S, Chapot B, Ito N, Montesano R.
    Cancer Epidemiol Biomarkers Prev; 1996 Mar 15; 5(3):179-89. PubMed ID: 8833618
    [Abstract] [Full Text] [Related]

  • 13. Inhibition of aflatoxin Ml excretion in rat urine during dietary intervention with oltipraz.
    Scholl P, Musser SM, Kensler TW, Groopman JD.
    Carcinogenesis; 1996 Jun 15; 17(6):1385-8. PubMed ID: 8681461
    [Abstract] [Full Text] [Related]

  • 14. Temporal patterns of aflatoxin-albumin adducts in hepatitis B surface antigen-positive and antigen-negative residents of Daxin, Qidong County, People's Republic of China.
    Wang JS, Qian GS, Zarba A, He X, Zhu YR, Zhang BC, Jacobson L, Gange SJ, Muñoz A, Kensler TW.
    Cancer Epidemiol Biomarkers Prev; 1996 Apr 15; 5(4):253-61. PubMed ID: 8722216
    [Abstract] [Full Text] [Related]

  • 15. Biological relevance of adduct detection to the chemoprevention of cancer.
    Sharma RA, Farmer PB.
    Clin Cancer Res; 2004 Aug 01; 10(15):4901-12. PubMed ID: 15297390
    [Abstract] [Full Text] [Related]

  • 16. Molecular dosimetry of urinary aflatoxin-N7-guanine and serum aflatoxin-albumin adducts predicts chemoprotection by 1,2-dithiole-3-thione in rats.
    Groopman JD, DeMatos P, Egner PA, Love-Hunt A, Kensler TW.
    Carcinogenesis; 1992 Jan 01; 13(1):101-6. PubMed ID: 1733561
    [Abstract] [Full Text] [Related]

  • 17. [Detection of aflatoxin-albumin adducts in human serum and its application].
    Sun G, He X, Qian G, Pu Y.
    Wei Sheng Yan Jiu; 2001 May 01; 30(3):185-8. PubMed ID: 12525098
    [Abstract] [Full Text] [Related]

  • 18. Temporal patterns of DNA adduct formation and glutathione S-transferase activity in the testes of rats fed aflatoxin B1: a comparison with patterns in the liver.
    Sotomayor RE, Sahu S, Washington M, Hinton DM, Chou M.
    Environ Mol Mutagen; 1999 May 01; 33(4):293-302. PubMed ID: 10398377
    [Abstract] [Full Text] [Related]

  • 19. Modulation of aflatoxin toxicity and biomarkers by lycopene in F344 rats.
    Tang L, Guan H, Ding X, Wang JS.
    Toxicol Appl Pharmacol; 2007 Feb 15; 219(1):10-7. PubMed ID: 17229449
    [Abstract] [Full Text] [Related]

  • 20. The formation of AFB(1)-macromolecular adducts in rats and humans at dietary levels of exposure.
    Cupid BC, Lightfoot TJ, Russell D, Gant SJ, Turner PC, Dingley KH, Curtis KD, Leveson SH, Turteltaub KW, Garner RC.
    Food Chem Toxicol; 2004 Apr 15; 42(4):559-69. PubMed ID: 15019179
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.